AzTrials
AzTrials

Cryotherapy EffectNCT05441995

Cryotherapy Efficacy During Pulp Therapy of the Mandibular First Permanent Molars in Children

A study testing Cryotherapy in people with Cryotherapy Effect and Irreversible Pulpitis, run by Minia University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the study is to assess the efficacy of cryotherapy application on the success of inferior alveolar nerve block (IANB) in reducing pain during pulp therapy of the mandibular first permanent molars with irreversible pulpitis (IP) in children age from 7 to 16 years. Read more about this study

Who is it for?
Ages 9 to 17 yearsHealthy volunteers can take part
Conditions the study is for
Cryotherapy Effect, Irreversible Pulpitis, Pain
What is being tested?
Cryotherapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
140 participants
Where
1 siteEgypt
Study dates
Jun 2022to Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 9 to 17 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Healthy children aged 9-17 years who were categorized as class I or II according to the ASA classification.
  • Cooperative children (rate 3 or 4 according to Frankl behavior rating scale)
  • Presence of a vital mandibular first permanent molar with SIP, the tooth should show deep caries or dental restorations with a history of spontaneous lingered pain precipitated by thermal stimuli. To confirm the diagnosis of irreversible pulpitis, early response to electric pulp and thermal testing was performed.
  • No radiographic changes with at least two-thirds of the root must be evident.

Who cannot join

  • Children with severe emotional, intellectual, and behavioral difficulties.
  • Necrotic pulp of primary molars.
  • Unrestorable crowns
  • Positive history of gingival swelling, abnormal mobility, and fistulous tract.
  • Presence of radiographic signs of periapical and/or furcation radiolucency, and pathological resorption.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Minia University

    Minya, Minya Governorate, 61111

    Omar Ahmed, 0020862347768, EG135.30708112400351@nies-edu.org

Other trials in Egypt

About this study

Official title: Cryotherapy Efficacy in 9 to17-year-old Children During Endodontic Treatment of the Mandibular First Permanent Molars With Symptomatic Irreversible Pulpitis: a Randomized Parallel Controlled Trial

The aim of the study is to assess the efficacy of cryotherapy application on the success of inferior alveolar nerve block (IANB) in reducing pain during pulp therapy of the mandibular first permanent molars with irreversible pulpitis (IP) in children age from 7 to 16 years. The null hypothesis (H0) supposed no difference in pain intensity during pulp therapy of primary molars with IP anesthetized with IANB with and without cryotherapy application. The secondary aim was to evaluate the children's behavior before and after pulpectomy in the two groups.

Being tested
Cryotherapy
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CryotherapyOther

    Ice packs were applied in the buccal mucosa related to the tooth for 5 minutes after IANB administration

Study groups in NCT05441995
Study groupRoleWhat they receive
CryotherapyExperimentalNot described
Receives: Other: Cryotherapy
Inferior alveolar nerve blockActive comparatorNot described
Receives: Other: Cryotherapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity

    Pain was assessed using Visual Analogue Scale (VAS)

    Measured: up to 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jul 2022
  2. Study startJun 2022 (estimated)
  3. Primary completionAug 2022 (estimated)
  4. Study completionAug 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
140 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05441995
Sponsor's protocol ID
630
Status last verified
Jun 2022
First submitted
28 Jun 2022
Last updated
1 Jul 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Cryotherapy in people with Cryotherapy Effect and Irreversible Pulpitis, run by Minia University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity (time frame: up to 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in